Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Access icon
Depression (MDD)

Insights April 6, 2021

Switching Versus Augmentation in Patients With Inadequate Antidepressant Response

Madhukar H. Trivedi, MD ; George I. Papakostas, MD ; W. Clay Jackson, MD, DipTh ; Roueen Rafeyan, MD, DFAPA, FASAM

J Clin Psychiatry 2020;81(3):OT19037BR3

Expert discuss why clinicians often switch antidepressants before considering augmentation strategies, as well as the potential consequences of those treatment decisions.


Read the eReport

Save Save

Share Share

Cite Cite

Related News Articles

Ketamine-Assisted Model Confirms Link to Depression Relief Restrictive Diets Could Make Depression Worse Beyond Juneteenth: The Mental Health Crises Facing Black Youth

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Differentiating Subtypes of MDD Using Serum Biomarkers Outpatient Ketamine Prescribing Practices in Psychiatry in the US: A Nationwide Survey Study Prediction Of Adolescent Suicidal Events By Residual Depressive Symptoms

Related PCC Articles

Efficacy of GLP-1 Agonists in Mental Disorders Psychological Morbidities in Hospital Staff During Nipah Virus Hypnotic Suggestion in Ketamine-Assisted Psychotherapy

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
Insights

Patient Functioning and Life Engagement: Treatment Goals in MDD

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
Michael E. Thase , Christoph U. Correll , Roger S. McIntyre , et al
JCP
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
Insights

Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy

May 17, 2022

Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
Raymond W. Lam
JCP
Progression of Symptoms Over the Course of Bipolar Disorder
Insights

Progression of Symptoms Over the Course of Bipolar Disorder

April 13, 2021

Dr Joseph F. Goldberg discusses how symptoms and clinical presentation change over time in people with bipolar disorder, beginning from the prodromal phase
Joseph F. Goldberg

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap